Eleazar Omar Macedo

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

Michiel S. van der Heijden, Matthew D. Galsky, Yohann Loriot et al. · The Lancet Oncology · 2020 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Association of Depression and Anxiety on Quality of Life, Treatment Adherence, and Prognosis in Patients with Advanced Non-small Cell Lung Cancer

Óscar Arrieta, Laura Angulo, Carolina Núñez-Valencia et al. · Annals of Surgical Oncology · 2012 · 344 citations

Medicine, Oncology, Psychiatry +13

First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial

Óscar Arrieta, Luis A. Medina, Enrique Estrada-Lobato et al. · British Journal of Cancer · 2012 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17